Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

LGD-4033 and Phenylpiracetam Interaction: Monitor | Peptide Database

Compound Profiles LGD-4033 Selective Androgen Receptor Modulator | Lean Mass LGD-4033 binds to the androgen receptor with high affinity (Ki of approximately 1 nM), functioning as a potent and selective agonist in muscle and bone tissue. Like other SARMs, its t

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

LGD-4033

Selective Androgen Receptor Modulator | Lean Mass

LGD-4033 binds to the androgen receptor with high affinity (Ki of approximately 1 nM), functioning as a potent and selective agonist in muscle and bone tissue. Like other SARMs, its tissue selectivity is mediated by differential cofactor recruitment: upon binding to the AR, LGD-4033 induces a receptor conformation that preferentially recruits coactivators expressed in skeletal muscle and bone, while showing minimal agonist activity in androgen-sensitive tissues such as the prostate and skin.

Phenylpiracetam

Racetam Nootropic | Cognitive & Physical Performance

Phenylpiracetam modulates multiple neurotransmitter systems, which accounts for its broad spectrum of cognitive and physical effects. Like other racetams, it acts as a positive allosteric modulator of AMPA receptors, enhancing glutamatergic transmission and facilitating long-term potentiation in hippocampal circuits critical for memory formation.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take LGD-4033 with Phenylpiracetam?

Yes, but with caution. Both LGD-4033 and Phenylpiracetam can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). Regular monitoring is advised.

Is LGD-4033 and Phenylpiracetam safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: blood pressure raising, teratogenic. Monitor accordingly.

What are the interactions between LGD-4033 and Phenylpiracetam?

Both LGD-4033 and Phenylpiracetam can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time LGD-4033 and Phenylpiracetam?

LGD-4033 has a half-life of ~24-36 hours and Phenylpiracetam has a half-life of ~3-5 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

What evidence supports FGL for human cognitive enhancement?

FGL research is primarily in animal models, where it enhances spatial memory, promotes hippocampal neurogenesis, and protects neurons from excitotoxicity. No human clinical trials exist yet. Evidence remains preclinical, making it a high-risk, exploratory peptide suitable only for research contexts with medical awareness of limited human safety data.

Source: peptide-db.com ↗

Research Indications

Used as a rescue compound when gynecomastia is actively progressing despite other interventions. Letrozole's extreme potency can rapidly suppress the estrogen driving breast tissue growth. Typically used short-term at low doses until the flare subsides, then transitioned to a milder AI or SERM for maintenance. On cycles involving high doses of testosterone or other heavily aromatizing compounds (e.g., testosterone above 750mg/week, or stacked with Dianabol), estrogen production may exceed what anastrozole can manage. Letrozole at conservative doses (0.25mg EOD) can provide the additional suppression needed. The primary challenge with letrozole is avoiding excessive estrogen suppression. Even small dose adjustments can dramatically impact estradiol levels. Requires frequent bloodwork and careful titration -- starting at the lowest effective dose and increasing only if confirmed necessary by labs. FDA-approved as adjuvant therapy and extended adjuvant therapy for hormone receptor-positive breast cancer in postmenopausal women. The BIG 1-98 trial demonstrated superior disease-free survival compared to tamoxifen, establishing letrozole as a first-line AI in oncology. Widely used off-label as a first-line treatment for ovulation induction in women with polycystic ovary syndrome (PCOS) or unexplained infertility. Letrozole has shown superior live birth rates compared to clomiphene citrate in multiple clinical trials. For individuals who aromatize heavily due to genetics, high body fat, or supraphysiological androgen doses, and who do not achieve adequate estrogen control with anastrozole. Letrozole at micro-doses may provide the potency needed, but the margin of error is slim. Short-term use to rapidly bring estradiol into range before transitioning to a less potent AI for ongoing management. This approach uses letrozole's strength while minimizing the risks of prolonged exposure.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Dutasteride is administered as an oral soft gelatin capsule at 0.5mg. The capsules should be swallowed whole and not chewed or opened, as the contents may irritate the oropharyngeal mucosa. It can be taken with or without food. Due to its extremely long half-life of approximately 5 weeks, some users adopt a reduced-frequency protocol of 3 times per week while still maintaining significant DHT suppression. Steady-state blood levels are reached after approximately 6 months of daily dosing. Hair loss treatment (standard daily) 0.5mg Once daily Oral soft gelatin capsule Hair loss treatment (reduced frequency) 3x per week (e.g., Mon/Wed/Fri) Benign Prostatic Hyperplasia

Source: peptide-db.com ↗
Side effects

Common Side Effects

Generally well-tolerated Injection site reactions (mild, if injectable) Minimal reported side effects

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides